Luke Evnin

Director

Luke Evnin (Director) filed 4 Form 4 reports in the trailing twelve months (0 purchases, 4 sales), most often in Werewolf Therapeutics, Inc. (HOWL). The largest single filing was $214K of HOWL (305,741 sh × $0.70, as filed), executed May 8.

Add to watchlist

Return, ttmiAverage return per filing, trailing twelve months

–

no purchases on file

Delay-adjustediThe same average, entered at disclosure dates

–

returns measure stock purchases only

Filings, ttm

0 buys · 4 sells

Median delay

–

execution → disclosure

Volume, ttmiDollar value disclosed in the trailing twelve months

$579K

shares × price, as filed

Last traded

May 8

Filed May 12

Median ADV $290K across their filed names

Open performance→

Volume by month

Buys $0 Sells $579K

Shares × price, as filed · by filing month · past 24 months

Sectors filed on

Healthcare 4 filings

Sector per market data · by filing · past 12 months

Most traded names

HOWL

Werewolf Therapeutics, Inc. HOWL · 0 buys · 4 sells 4 filings

Recent filings

HOWLSALE Werewolf Therapeutics, Inc. View filing → $214K
305,741 sh × $0.70
Exec May 8
Filed May 12 · 5:30 PM ET HOWLSALE Werewolf Therapeutics, Inc. View filing → $121K
168,262 sh × $0.72
Exec Apr 30
Filed May 4 · 5:30 PM ET HOWLSALE Werewolf Therapeutics, Inc. View filing → $110K
90,164 sh × $1.22
Exec Nov 4 2025
Filed Nov 6 2025 · 5:30 PM ET HOWLSALE Werewolf Therapeutics, Inc. View filing → $134K
86,154 sh × $1.55
Exec Oct 29 2025
Filed Oct 29 2025 · 5:30 PM ET